FMR LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$110,493,263
-13.3%
5,301,980
-0.4%
0.01%
-9.1%
Q2 2023$127,443,626
-56.8%
5,321,237
-66.1%
0.01%
-21.4%
Q1 2023$295,348,772
+98.7%
15,693,346
+68.1%
0.01%
-6.7%
Q4 2022$148,607,055
-21.5%
9,334,614
-19.3%
0.02%
-25.0%
Q3 2022$189,302,000
+8.4%
11,571,025
-6.7%
0.02%
+17.6%
Q2 2022$174,701,000
-46.5%
12,398,957
-8.0%
0.02%
-34.6%
Q1 2022$326,520,000
+1.1%
13,481,449
-2.6%
0.03%
+8.3%
Q4 2021$323,043,000
+22.5%
13,840,750
-12.8%
0.02%
+14.3%
Q3 2021$263,710,000
-30.2%
15,876,544
+2.4%
0.02%
-30.0%
Q2 2021$378,024,000
-14.8%
15,499,138
-9.8%
0.03%
-21.1%
Q1 2021$443,437,000
-57.4%
17,187,483
-11.7%
0.04%
-59.1%
Q4 2020$1,041,023,000
+27.8%
19,472,914
-1.4%
0.09%
+13.4%
Q3 2020$814,619,000
-19.2%
19,748,348
-5.0%
0.08%
-26.1%
Q2 2020$1,007,706,000
+17.5%
20,790,304
+2.5%
0.11%
-6.7%
Q1 2020$857,291,000
-4.1%
20,290,897
-2.9%
0.12%
+20.2%
Q4 2019$893,714,000
+9.2%
20,890,917
-8.2%
0.10%
+1.0%
Q3 2019$818,637,000
+41.6%
22,746,244
+5.2%
0.10%
+44.1%
Q2 2019$578,033,000
-0.3%
21,624,888
+0.2%
0.07%
-1.4%
Q1 2019$579,486,000
+66.3%
21,582,357
+0.2%
0.07%
+43.8%
Q4 2018$348,364,000
-10.5%
21,543,893
+14.9%
0.05%
+9.1%
Q3 2018$389,271,000
+36.1%
18,751,008
+0.1%
0.04%
+33.3%
Q2 2018$285,914,000
-32.0%
18,723,895
+0.1%
0.03%
-34.0%
Q1 2018$420,308,000
-25.1%
18,705,291
+0.4%
0.05%
-24.2%
Q4 2017$560,974,000
-18.9%
18,630,845
+1.5%
0.07%
-21.4%
Q3 2017$691,623,000
+35.5%
18,360,045
+0.3%
0.08%
+33.3%
Q2 2017$510,582,000
-18.5%
18,306,966
+0.5%
0.06%
-21.2%
Q1 2017$626,099,000
+19.5%
18,211,143
+0.2%
0.08%
+14.3%
Q4 2016$523,938,000
-9.0%
18,167,076
+0.4%
0.07%
-9.1%
Q3 2016$575,708,000
+4.5%
18,098,352
+6.7%
0.08%
+2.7%
Q2 2016$550,828,000
+16.6%
16,969,451
+0.5%
0.08%
+15.4%
Q1 2016$472,257,000
-12.5%
16,890,468
+11.6%
0.06%
-11.0%
Q4 2015$539,625,000
+8.0%
15,136,743
+0.2%
0.07%
+2.8%
Q3 2015$499,596,000
-20.7%
15,107,227
+0.4%
0.07%
-12.3%
Q2 2015$630,068,000
+28.7%
15,044,613
+0.1%
0.08%
+30.6%
Q1 2015$489,689,000
+3.1%
15,025,757
+0.4%
0.06%0.0%
Q4 2014$475,156,000
+28.7%
14,965,545
+0.3%
0.06%
+24.0%
Q3 2014$369,308,000
+10.1%
14,915,523
+0.5%
0.05%
+11.1%
Q2 2014$335,313,000
-5.8%
14,843,448
+1.5%
0.04%
-8.2%
Q1 2014$355,836,000
+4.5%
14,625,393
+7.3%
0.05%
+2.1%
Q4 2013$340,613,000
-7.0%
13,629,970
+2.3%
0.05%
-14.3%
Q3 2013$366,124,000
+52.2%
13,328,165
+0.6%
0.06%
+43.6%
Q2 2013$240,573,00013,254,7350.04%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 432,317$11,154,0004.70%
Baker Brothers Advisors 41,910,704$1,081,296,0004.69%
Palo Alto Investors LP 2,337,877$60,317,0003.44%
Birchview Capital, LP 177,000$4,567,0002.71%
Longitude (Cayman) Ltd. 188,000$4,850,0001.86%
GREAT POINT PARTNERS LLC 311,217$8,029,0001.66%
Avoro Capital Advisors LLC 2,500,000$64,500,0001.11%
PFM Health Sciences, LP 1,302,129$33,595,0001.03%
HealthCor Management, L.P. 900,490$23,233,0000.82%
Eversept Partners, LP 420,000$10,836,0000.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders